Tag: Eli Lilly

While competitors grapple with supply constraints, Eli Lilly is making an aggressive move to solidify its market position. The pharmaceutical ...

Pharmaceutical leader Eli Lilly finds itself balancing ambitious growth initiatives with increased regulatory oversight. The company recently announced its largest ...

Eli Lilly finds itself navigating regulatory challenges as the U.S. Food and Drug Administration takes issue with the pharmaceutical giant's ...

Eli Lilly and Company is executing an ambitious growth strategy through simultaneous manufacturing expansion and clinical development. The pharmaceutical giant ...

Eli Lilly has delivered a decisive victory in a head-to-head clinical trial against competitor Novo Nordisk, with results exceeding market ...

After weathering months of downward pressure, Indianapolis-based pharmaceutical giant Eli Lilly is demonstrating renewed strength. A series of significant developments ...

Eli Lilly confronts significant challenges this week as a US appellate court upheld a substantial $184 million penalty against the ...

Eli Lilly and Company shares are currently exhibiting a classic technical consolidation pattern, caught between well-defined support and resistance levels. ...

Friday proved to be a turbulent day for pharmaceutical giant Eli Lilly, with three significant developments creating a complex picture ...

Eli Lilly has generated significant attention in oncology circles following the FDA's decision to grant its lung cancer treatment Olomorasib ...